Physicians should prescribe the best course of treatment for their cancer patients, even if the proposed treatment falls within the experimental treatment clauses in health insurance coverage.
The Supreme Court’s ruling in Riegel v. Medtronic, Inc., may prevent consumers injured by medical devices that have FDA premarket approval from receiving compensation.
An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in.